Case Study: BioPharma – CDMO Requires Quality, Speed and Service
This Case Study demonstrates how the pressures of CDMOs to support their clients can be intense. GeminiBio discusses the importance of the ability of CDMOs to manage their processes whilst accommodating to their client’s needs as well as other factors that may affect the their ability to demonstrate flexibility.

With the rapid proliferation of novel cell and gene therapy technologies there has been a concomitant expansion of contract development and manufacturing organizations (CDMOs) to provide the development and/or manufacturing infrastructure required to enable these technologies to advance through the clinical development process. Given the competitive nature of the market – where companies are racing to be first to market in their respective therapeutic areas – the pressure on CDMOs to support their clients is often intense, as well as challenging.

Download the full Case Study to find out more.

This Case Study has been produced in partnership with GeminiBio.